| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |